SCHEMBL29486304

SCHEMBL29486304

CCC(C(N)=O)N1CC(c2cccc(N=[N+]=[N-])c2)CC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.50
DPP9 Q86TI2 1/20 0.37
LMNA P02545 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
PDE4A P27815 2/20 0.32
PDE4B Q07343 2/20 0.32
PDE4C Q08493 2/20 0.32
PDE4D Q08499 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14202858 1.00 RIPK1 (0.50) RIPK1DPP9LMNACA12CA1
SCHEMBL13437890 1.00 RIPK1 (0.50) RIPK1DPP9LMNACA12CA1
SCHEMBL15720799 0.92 RIPK1 (0.48) RIPK1DPP9LMNACA12CA1
SCHEMBL27826951 0.90 RIPK1 (0.46) RIPK1DPP9LMNACA12CA1
SCHEMBL15721014 0.88 RIPK1 (0.45) RIPK1DPP9LMNACA12CA1
SCHEMBL16058042 0.88 RIPK1 (0.47) RIPK1DPP9LMNACA12CA1
SCHEMBL23111179 0.87 LMNA (0.38) RIPK1DPP9LMNACA12CA1
SCHEMBL27947215 0.85 RIPK1 (0.46) RIPK1DPP9LMNACA12CA1
SCHEMBL563294 0.82 LMNA (0.40) LMNACA12CA1CA2CA3
SCHEMBL563451 0.82 LMNA (0.40) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112088160-B 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives UCB生物制药有限责任公司 2023-07-04 CN disclosed
EP-3790885-B1 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES UCB Biopharma SRL (BE) 2023-04-19 EP disclosed
CN-110869374-B 2-oxo-1, 3-oxazolidinyl imidazothiadiazole derivatives UCB生物制药有限责任公司 2022-08-30 CN disclosed
CN-110869375-B 2-oxo-1-imidazolidinylimidazothiadiazole derivatives UCB生物制药有限责任公司 2022-08-30 CN disclosed
US-11286266-B2 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives UCB Biopharma SRL 2022-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11286266-B2 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives TPMT, THPO, PKD1 RIPK1 3799/4885DPP9 201/4885LMNA 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.